You are here

From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Note: This is an archived resource. It is provided here for general reference, but users are advised to refer to other sources to confirm information. See full site Disclaimer.


  • Describe the financial impact of HCV treatment
  • Identify current restrictions to HCV treatment common among third party payers
  • Illustrate successful navigation through the prior authorization and appeal process
  • Review criteria and options for patient assistance programs (PAP)


Autumn Bagwell PharmD BCPS

Add comment

Log in to post comments